Effects of Urtica dioica Seeds on Oxidative/ Nitrosative Stress Levels and Myeloperoxidase Activity in Muscle Ischemia/Reperfusion Injury

Abstract The purpose of this study is to evaluate the preventive effects of Urtica dioica (UD) on muscle ischemia/reperfusion (I/R) injury. A total of 27 male Wistar rats were divided into three groups as the control group (1), I/R + saline group (2), and I/R+UD group (3). Group 1 did not receive any treatment. Group 2 was administered a total of 2mL/kg saline (1mL/kg before ischemia and 1 mL/kg after reperfusion), and group 3 was given a total of 2mL of UD (1mL/kg before ischemia and 1mL/kg after reperfusion) as treatment. Saline and UD were administered via intraesophageal canula once a day for five days. At the end of five days, all the rats were exposed to muscle ischemia for 60 min followed by 60 min of reperfusion of the bilateral hindlimbs induced using a tourniquet. Muscle tissue histopathologies were evaluated by light microscopy. Furthermore, oxidative/nitrosative stress biomarkers such as catalase (CAT), superoxide dismutase (SOD), malondialdehyde (MDA), nitrotyrosine (3-NT), nitric oxide (NO), and myeloperoxidase (MPO) as an inflammatory marker in tissue samples were measured. UD treatment significantly decreased oxidative/nitrosative stress biomarker levels and MPO (p<0.05). We established that UD treatment could alleviate muscle injury induced by muscle I/R in rats by inhibiting the inflammation and oxidative/nitrosative stress

Simultaneous use of oxalate-degrading bacteria and herbal extract to reduce the urinary oxalate in a rat model: A new strategy

ABSTRACT Objective: Urinary stones with oxalate composition can cause kidney failure. Recent findings evidenced that probiotics are effective in reducing oxalate absorption in these subjects based on their high colonic absorption levels at baseline. The purpose of this study was to evaluate the effect of the simultaneous use of oxalate-degrading bacteria, Urtica dioica and T. terrestris extract in reducing urinary oxalate. Materials and Methods: Anti-urolithiatic activity of Urtica dioica and T. terrestris extract and probiotic by using ethylene glycol induced rat model. In this study, 4 strains of Lactobacillus and 2 strains of Bifidobacterium and also 2 strains of L. paracasei (that showed high power in oxalate degrading in culture media) were used. Male Wistar rats were divided into four groups (n=6). The rats of group-I received normal diet (positive control group) and groups-II (negative control group), III, IV rats received diet containing ethylene glycol (3%) for 30 days. Groups III rats received Urtica dioica and T. terrestris extract. Groups IV rats received extracts + probiotic for 30 days. Findings: The results show that the use of herbal extracts (Urtica dioica and T. terrestris) reduced the level of urinary oxalate and other parameters of urine and serum. Also, the accumulation of calcium oxalate crystals in the kidney tissue was significantly reduced. Conclusion: Considering that the formation of calcium oxalate crystals can cause inflammation and tissue damage in the kidney, the use of herbal extracts with oxalate degrading bacteria can be a new therapeutic approach to preventing the formation of kidney stones.

Immunohistopathological and Biochemical Study of the Effects of Dead Nettle (Urtica Dioica) Extract on Preventing Liver Lesions Induced by Experimental Aflatoxicosis in Rats / Estudio inmunohistopatológico y bioquímico de los efectos del extracto de la ortiga mayor (Urtica dioica) en la prevención de lesiones hepáticas inducidas por aflatoxicosis experimental en ratas

ABSTRACT Objective: Aflatoxicosis is a mycotoxicosis infection with an acute or chronic course that forms due to aflatoxins (AFs) in humans and animals. Aflatoxins primarily affect the liver and can lead to histopathological necrosis, fibrosis and hepatocarcinogenesis of the organ. This paper studied the preventive effects of dead nettle leaf (Urtica dioica leaf; UDL) extract on liver lesions that were induced by experimental aflatoxicosis in rats. Methods: A total of 30 rats were separated into three groups of 10 rats each. Experimental group A (control) received normal rat food, experimental group B (AFB1) received 2 mg/kg of AF, and experimental group C (AFB1 + UDL extract) received 2 mg/kg of AF + 2 ml/rat/day of UDL extract. After three months of experimentation, blood and tissue samples were taken from the rats by necropsy to perform chemical and histopathological analyses. Results: According to the biochemical and histopathological findings, antioxidant system activity increased and lipid peroxidation and liver enzyme levels decreased in the group that received UDL extract. Conclusion: The extract of UDL had hepatoprotective effects against aflatoxicosis.

RESUMEN Objetivo: La aflatoxicosis es una infección por micotoxicosis con un curso agudo o crónico producido por aflatoxinas (AF) en seres humanos y animales. Las aflatoxinas afectan principalmente el hígado y pueden conducir a necrosis histopatológica, fibrosis o hepatocarcinogénesis del órgano. En este trabajo se estudiaron los efectos preventivos del extracto de la hoja de ortiga mayor (Urtica dioica l; UDL) sobre las lesiones hepáticas inducidas por aflatoxicosis experimental en ratas. Métodos: Un total de 30 ratas se separaron en tres grupos de 10 ratas cada una. EL grupo experimental A (control) recibió comida normal de ratas; el grupo experimental B (AFB1) recibió 2 mg/kg de AF; y el grupo experimental C (AFB1 + extracto de UDL) recibió 2 mg/kg de AF + 2 ml/rata/día de extracto de UDL. Después de tres meses de experimentación, se tomaron muestras de sangre y tejidos de las ratas en una necropsia encaminada a realizar análisis químicos e histopatológicos. Resultados: Según los hallazgos bioquímicos e histopatológicos, la actividad del sistema antioxidante aumentó, y la peroxidación del lípido y los niveles de la enzima del hígado disminuyeron en el grupo que recibió el extracto de UDL. Conclusión: El extracto de UDL tuvo efectos hepatoprotectores contra la aflatoxicosis.

The preventive and treatment effect of urtica dioica on astrocyte density in the CA1 and CA3 subfields of hippocampus in STZ induced diabetic rats / Efecto preventivo y del tratamiento de urtica dioica sobre la densidad de astrocitos en los subcampos CA1 y CA3 del hipocampo en ratas con diabetes inducida por STZ

Several animal model studies have shown that Diabetes mellitus can affect on the activity of hippocampus astrocytes, but these studies reported controversial findings. This study was done to evaluate the preventive and treatment effect of Urtica dioica (U. dioica) on astrocytes density in the CA1 and CA3 subfields of hippocampus of streptozotocin (STZ) induced diabetic rats. Twenty-eight male albino Wistar rats were randomly allocated equally into control, diabetic, U. dioica treatment and U. dioica preventive groups. Hyperglycemia was induced by STZ (80 mg/kg/BW). One week after injection of the streptozotocin, animals in treatment group were received hydroalcoholic extract of U. dioica (100 mg/kg/BW /day) for 4 weeks by intraperitoneally. In preventive group, diabetic rats were received 100 mg/kg/BW/ daily hydroalcoholic extract of U. dioica for 5 days before STZ injection. Then, animals were sacrificed and coronal sections were taken from the right dorsal hippocampus, stained with PTAH. The area densities of the astrocytes were measured. The number of astrocytes in CA1 of controls, diabetic treatment and preventive groups was 19.00+/-5.5, 17.14+/-6.4, 21+/-8.1 and 16.48+/-3.2, respectively. The densities of astrocytes in CA3 of controls, diabetic, treatment and preventive groups were 25.45+/-7.60, 21.54+/-7.5, 23.75+/-5.6 and 19.89+/-3.8, respectively. The density of astrocytes in diabetic rats reduced in comparison with controls (P<0.05). In CA1 and CA3, in spite of preventive administration, treatment of diabetic rats with U. dioica significantly increased the astrocytes. This study showed that treatment with U. dioica extract can help compensate for the CA1 and CA3 subfields of hippocampus astrocytes in diabetic rats.

Varios estudios en modelos animales han mostrado que la diabetes mellitus puede afectar la actividad de los astrocitos del hipocampo, pero estos resultados son controvertidos. Este estudio se realizó para evaluar el efecto preventivo y de tratamiento de la Urtica dioica (U. dioica) en la densidad de los astrocitos en los subcampos CA1 y CA3 del hipocampo en ratas diabéticas inducidas por estreptozotocina (STZ). Veintiocho ratas Wistar albinas macho fueron asignadas al azar por igual en grupos control, diabético, con tratamiento U. dioica y preventivo con U.dioica. La hiperglucemia se indujo por STZ (80 mg/kg/peso corporal). Una semana después, los animales del grupo tratamiento recibieron el extracto hidroalcohólico de U. dioica (100 mg/kg/peso corporal/día) durante 4 semanas vía intraperitoneal. El grupo preventivo, recibió 100 mg/kg/peso corporal/día de extracto hidroalcohólico U. dioica durante 5 días antes de la inyección de STZ. Los animales fueron sacrificados, se tomaron secciones coronales del hipocampo dorsal derecho y se tiñeron con PTAH. Fueron medidas las densidades de área de los astrocitos. El número de astrocitos en CA1 de los grupos de ratas control, diabéticas, con tratamiento de U. dioica y preventivo con U. dioica fue 19,00+/-5,5, 17,14+/-6,4, 21+/-8,1 y 16,48+/-3,2, respectivamente. Las densidades de los astrocitos en CA3 de los grupos de ratas control, diabéticas, con tratamiento de U. dioica y preventivo con U. dioica fue 25,45+/-7,60, 21,54+/-7,5, 23,75+/-5,6 y 19,89+/-3,8, respectivamente. La densidad de los astrocitos en las ratas diabéticas se redujo en comparación con los controles (P <0,05). En CA1 y CA3, a pesar de la administración preventiva, sólo el tratamiento de ratas diabéticas con U. dioica aumentó significativamente los astrocitos. Este estudio mostró que el tratamiento con extracto de U. dioica puede ayudar a compensar los astrocitos de los subcampos CA1 y CA3 del hipocampo en ratas diabéticas.

Anti-mycobacterial screening of five Indian medicinal plants and partial purification of active extracts of Cassia sophera and Urtica dioica

OBJECTIVE@#To find out the anti-mycobacterial potential of Cassia sophera (C. sophera), Urtica dioica (U. dioica), Momordica dioica, Tribulus terrestris and Coccinia indica plants against multi-drug resistant (MDR) strain of Mycobacterium tuberculosis (M. tuberculosis).@*METHODS@#Plant materials were extracted successively with solvents of increasing polarity. Solvent extracts were screened for anti-mycobacterial activity against fast growing, non-pathogenic mycobacterium strain, Mycobacterium semegmatis, by disk diffusion method. The active extracts were tested against MDR and clinical isolates of M. tuberculosis by absolute concentration and proportion methods. The active extracts were subjected to bio-autoassay on TLC followed by silica column chromatography for isolation of potential drug leads.@*RESULTS@#Hexane extract of U. dioica (HEUD) and methanol extract of C. sophera (MECS) produced inhibition zone of 20 mm in disc diffusion assay and MIC of 250 and 125 μ g/mL respectively in broth dilution assay against Mycobacterium semegmatis. Semipurified fraction F2 from MECS produced 86% inhibition against clinical isolate and 60% inhibition against MDR strain of M. tuberculosis. F18 from HEUD produced 81% inhibition against clinical isolate and 60% inhibition against MDR strain of M. tuberculosis. Phytochemical analysis indicated that anti-mycobacterial activity of MECS may be due to presence of alkaloids or flavonoids and that of HEUD due to terpenoids.@*CONCLUSIONS@#C. sophera and U. dioica plant extracts exhibited promising anti-mycobacterial activity against MDR strain of M. tuberculosis. This is the first report of anti-mycobacterial activity form C. sophera. This study showed possibility of purifying novel anti-mycobacterial compound(s) from C. sophera and U. dioica.

Screening antimicrobial activity of various extracts of Urtica dioica

Urtica dioica or stinging nettle is traditionally used as an herbal medicine in Western Asia. The current study represents the investigation of antimicrobial activity of U. dioica from nine crude extracts that were prepared using different organic solvents, obtained from two extraction methods: the Soxhlet extractor (Method I), which included the use of four solvents with ethyl acetate and hexane, or the sequential partitions (Method II) with a five solvent system (butanol). The antibacterial and antifungal activities of crude extracts were tested against 28 bacteria, three yeast strains and seven fungal isolates by the disc diffusion and broth dilution methods. Amoxicillin was used as positive control for bacteria strains, vancomycin for Streptococcus sp., miconazole nitrate (30µg/mL) as positive control for fungi and yeast, and pure methanol (v/v) as negative control. The disc diffusion assay was used to determine the sensitivity of the samples, whilst the broth dilution method was used for the determination of the minimal inhibition concentration (MIC). The ethyl acetate and hexane extract from extraction method I (EA I and HE I) exhibited highest inhibition against some pathogenic bacteria such as Bacillus cereus, MRSA and Vibrio parahaemolyticus. A selection of extracts that showed some activity was further tested for the MIC and minimal bactericidal concentrations (MBC). MIC values of Bacillus subtilis and Methicillin-resistant Staphylococcus aureus (MRSA) using butanol extract of extraction method II (BE II) were 8.33 and 16.33mg/mL, respectively; while the MIC value using ethyl acetate extract of extraction method II (EAE II) for Vibrio parahaemolyticus was 0.13mg/mL. Our study showed that 47.06% of extracts inhibited Gram-negative (8 out of 17), and 63.63% of extracts also inhibited Gram-positive bacteria (7 out of 11); besides, statistically the frequency of antimicrobial activity was 13.45% (35 out of 342) which in this among 21.71% belongs to antimicrobial activity extracts from extraction method I (33 out of 152 of crude extracts) and 6.82% from extraction method II (13 out of 190 of crude extracts). However, crude extracts from method I exhibited better antimicrobial activity against the Gram-positive bacteria than the Gram-negative bacteria. The positive results on medicinal plants screening for antibacterial activity constitutes primary information for further phytochemical and pharmacological studies. Therefore, the extracts could be suitable as antimicrobial agents in pharmaceutical and food industry.

Urtica dioica u ortiga se utiliza tradicionalmente como medicina herbaria en el oeste de Asia. En esta investigación se estudia la actividad antimicrobiana de nueve extractos crudos de U. dioica, los cuales fueron preparados utilizando diferentes disolventes orgánicos y obtenidos a partir de dos métodos de extracción: el extractor Soxhlet (Método I), que incluía el uso de cuatro disolventes con acetato de etilo y hexano, y las particiones secuenciales (Método II) con un sistema de cinco disolventes (butanol). Las actividades antibacterianas y antifúngicas de extractos crudos fueron ensayados contra 28 bacterias, tres cepas de levadura y siete cepas fúngicas por la difusión en disco y el método de dilución en caldo. La amoxicilina se utilizó como control positivo para cepas de bacterias, vancomicina para Streptococcus sp., nitrato de miconazol (30μg/mL) como control positivo para los hongos y levaduras, y el metanol puro (v / v) como control negativo. El ensayo de difusión en disco se utilizó para determinar la sensibilidad de las muestras, mientras que el método de dilución en caldo se utilizó para la determinación de la concentración de inhibición mínima (CIM). El acetato de etilo y el extracto de hexano del método de extracción I (AE I y EH I) mostraron mayor inhibición contra algunas bacterias patógenas tales como Bacillus cereus, MRSA y Vibrio parahaemolyticus. Una selección de extractos que mostraron algún tipo de actividad se probó para el CIM y las concentraciones mínimas bactericidas (CMB). Los valores de CIM de Bacillus subtilis y de Staphylococcus aureus resistentes a la meticilina (MRSA) usando extracto de butanol mediante el método de extracción II (EB II) fueron: 8.33 y 16.33mg/ mL, respectivamente; mientras que el valor de MIC con el uso del extracto de acetato de etilo por el Método de extracción II (EAE II) para Vibrio parahaemolyticus fue 0.13mg/mL. Nuestro estudio mostró que el 47.06% de los extractos inhibieron bacterias Gram-negativas (8 de 17), y el 63,63% de los extractos también inhibieron bacterias Gram-positivas (7 de 11), además que estadísticamente la frecuencia de la actividad antimicrobiana fue de 13.45% (35 de 342), que de este porcentaje un 21.71% pertenece alos extractos de actividad antimicrobiana con el método de extracción I (33 de 152 de los extractos crudos) y un 6.82% del método de extracción II (13 de 190 de los extractos crudos). Sin embargo, los extractos crudos del método I exhibieron una mejor actividad antimicrobiana contra las bacterias Gram-positivas que las Gram-negativas. Los resultados positivos en la detección de plantas medicinales para la actividad antibacteriana constituye información primaria para la realización de nuevos estudios fitoquímicos y farmacológicos. Por lo tanto, los extractos podrían ser adecuados como agentes antimicrobianos en la industria farmacéutica y de alimentos.

[Medicinal plants used in treatment of rhematologic diseases: a systematic review]

The rheumatologic diseases like osteoarthritis, rheumatoid arthritis, lowback pain and fibromyalgia are very common. The synthetic drugs available for treatment of these diseases have low efficacy and considerable adverse effects. Numerous approaches are used as alternatives and complementary to synthetic drugs to treat these diseases. One of the approaches is use of herbal medications. Here, the effects of medicinal plants and herbal active constituents used in treatment of these diseases including gammalinolenic acid, glucosamine, devil's claw [Harpagophytum procumbens], Ocimum species, Salix species, feverfew [Tanacetum parthenium], Tripterygium wilfordii, Uncaria species, nettle [Urtica dioica], ginger [Zingiber officinale], turmeric [Curcuma longa], chicory [Cichorium intybus], dog rose [Rosa canina] and avocado/soybean unsaponifiables obtained from search for english articles published in the databases PubMed and SCOPUS from 1966 to the end of 2011 using the keywords including the scientific, common and traditional names of plants are reviewed. Limited research has been conducted on the antirheumatic effects of these plants and active constituents so far. Thus it seems that further research to determine the mechanisms of action, drug interactions, efficacy and safety of medicinal plants and herbal active constituents potentially useful in treatment of these diseases are warranted

Alteration of dentate gyrus astrocytes in diabetic rats: protective role of urtica dioica / Alteración de los astrocitos del giro dentado en ratas diabéticas: rol protector de urtica dioica

Diabetes mellitus can cause astrocytes alterations in the central nervous system. Urtica dioica (Nettle) is among several species listed for their use against diabetes in folk medicine. Therefore, this study was done to evaluate the protective effect of Urtica dioica on astrocytes density of the dentate gyrus in STZ induced diabetic rats. In this experimental study, 21 male albino Wistar rats were randomly allocated equally into normal, diabetic and protective (nettle treated diabetic) groups. Hyperglycemia was induced by streptozotocin (80 mg/kg) in the animals of diabetic and treatment groups. Before induction of diabetes in animals, animals in protective group received hydroalcoholic extract of Urtica dioica (100 mg/kg/BW /day) for five days intraperitoneally. Four weeks after induction of diabetes, animals were sacrificed and coronal sections were taken from the dorsal hippocampal formation of the right cerebral hemispheres and stained with PTAH stain. The area densities of the astrocytes were measured and compared in the three groups (p < 0.05). The number of astrocytes in DG area of controls was 17.72+/-6.7. The density of astrocytes increased in diabetic (24.26+/-9.5) in comparison with controls. The density in the nettle treated rats (23.17+/-5.8) was lower than diabetic rats. This study showed that the administration of U. dioica extract before induction of diabetes can not significantly help compensate for astrocytes in the dentate gyrus of treated rats.

La diabetes mellitus puede provocar alteraciones de los astrocitos en el sistema nervioso central. La Urtica dioica (ortiga) es una de varias especies incluidas para su uso contra la diabetes en la medicina popular. Este estudio se realizó para evaluar el efecto protector de la Urtica dioica sobre la densidad de los astrocitos en el giro dentado en ratas con diabetes inducida por STZ. En este estudio experimental 21 ratas albinas Wistar fueron asignadas al azar equitativamente en grupos normal, diabético y protegido (diabéticos tratados con ortiga). La hiperglicemia fue inducida por estreptozotocina (80 mg/kg) en los grupos de animales diabéticos y en tratamiento protector. Previo a la inducción diabética, los animales del grupo protegido recibieron, por vía intraperitoneal, extracto hidroalcohólico de Urtica dioica (100 mg/kg/peso corporal/día) durante cinco días . Cuatro semanas después de la inducción de la diabetes, los animales fueron sacrificados y se tomaron secciones coronales de la formación del hipocampo dorsal de los hemisferios cerebrales derechos y se tiñeron con tinción PTAH. La densidad de área de los astrocitos fue medida y comparada en los tres grupos (p<0,05). El número de astrocitos en el área del giro dentado en los controles fue 17,72+/-6,7. La densidad de los astrocitos aumentó con la diabetes (24,26+/-9,5) en comparación con los controles. La densidad en las ratas tratadas con ortiga (23,17+/-5,8) fue menor que las ratas diabéticas. Este estudio demostró que la administración del extracto de U. dioica antes de la inducción diabética no ayuda significativamente a la compensación de los astrocitos en el giro dentados de las ratas tratadas.

Proliferation of the b -cells of pancreas in diabetic rats treated with Urtica dioica / Proliferación de las células b del páncreas en ratas diabéticas tratadas con Urtica dioica

This investigation was carried out to evaluate the effect of the extract of Urtica dioica leaves on hyperglycemia and quantitative changes of b-cells in streptozotocin-diabetic rats. Forty male Wistar rats were allocated in groups of normal, diabetic, treatment and protective. Hyperglycemia induced by administrating one dose of 80 mg/kg streptozotocin (STZ) intraperitoneally. Animals in treatment group received Urtica dioica (100 mg/kg/day) for 4 weeks intraperitoneally, one week after injection of STZ. In protective group animals received U. dioica (100 mg/kg/day) for 5 days before inducing diabetes. After five weeks the animals were sacrificed and whole pancreas removed. Pancreas specimens were used for quantitative morphometric analysis after Chromealum hematoxiline - phloxine staining. The mean +/- SE of b-cells in non hyperglycemic animals in protective group was higher than in hyperglycemic animals in the same group (54.33 +/- 2.4 versus 1.25 +/- 0.5, P<0.05). Hyperglycemia was improved in 6 (60 percent) of rats in protective group and 1 (10 percent) rat in treatment group OR=0.07 (CI 95 percent: 0.0-1.1, p=0.06). The logistic regression analysis showed an association between decrease of blood glucose, increase of number of b-cells and administration of Urtica before induction of diabetes. This study showed proliferation of b-cells when of the U. dioica leaves extract (100 mg/kg/day) administrated before induction of diabetes in animal model.

Este estudio evalúa el efecto del extracto de hojas de Urtica dioica sobre la hiperglicemia y de los cambios cuantitativos de células b en ratas diabéticas por estreptozotocina. Cuarenta ratas Wistar macho, fueron distribuidas en grupos normal, diabético, en tratamiento y protector. La hiperglicemia fue inducida, por vía intraperitoneal, a través de la administración de una dosis de 80 mg/kg de estreptozotocina (STZ) . Los animales del grupo en tratamiento recibieron Urtica dioica (100 mg/kg/día) durante 4 semanas por vía intraperitoneal, una semana después de la inyección de STZ. En los animales del grupo de protección recibieron U. dioica (100 mg/kg/día) durante 5 días antes de inducir la diabetes. Después de cinco semanas, los animales fueron sacrificados y se extirpó el páncreas. Muestras de páncreas se utilizaron para el análisis morfométrico cuantitativo después de la tinción hematoxilina/floxina. La media +/- SE de células b en los animales sin hiperglicemia y en el grupo de protección fue mayor que en los animales con hiperglicemia (54,33 +/- 2,4 frente a 1,25 +/- 0,5, p<0,05). La hiperglicemia mejoró en 6 (60 por ciento) de las ratas del grupo de protección y 1 (10 por ciento) de ratas en grupo de tratamiento OR=0,07 (IC 95 por ciento: 0,0-1,1, p=0,06). El análisis de regresión logística mostró una asociación entre la disminución de la glucosa en sangre, aumento del número de células b y la administración de Urtica antes de la inducción de la diabetes. Este estudio mostró una proliferación de las células b cuando el extracto de las hojas de U. dioica (100 mg/kg/día) administrado antes de la inducción de la diabetes en modelos animales.

Effects of Urtica dioica on hepatic ischemia-reperfusion injury in rats

OBJECTIVES: To evaluate the effects of Urtica dioica on hepatic ischemia-reperfusion injury. METHODS: Thirty adult male Wistar albino rats were divided into three groups: sham group (group 1), control group (group 2), and Urtica dioica group (group 3). All the rats were exposed to hepatic ischemia for 60 min, followed by 60 min of reperfusion. In group 2, a total of 2 ml/kg 0.9 percent saline solution was given intraperitoneally. In group 3, a total of 2 ml/kg Urtica dioica was given intraperitoneally. At the end of the procedure, liver tissue and blood samples were taken from all rats. Serum aspartate aminotransferase, alanine aminotransferase, lactate dehydrogenase, ceruloplasmin, catalase, paraoxonase, arylesterase, and lipid hydroperoxide levels were measured. Liver tissue histopathologies were also evaluated by light microscopy. RESULTS: Serum aspartate aminotransferase, alanine aminotransferase and lactate dehydrogenase levels were significantly higher in group 2 than in group 1, and significantly lower in group 3 than in group 2. Also, group 2 had higher serum lipid hydroperoxides and ceruloplasmin levels but lower catalase, paraoxonase, and arylesterase levels than group 1. In group 3, serum lipid hydroperoxides and ceruloplasmin levels were significantly lower, and catalase, paraoxonase, and arylesterase levels were higher than those in group 2. Histopathological examination showed that liver tissue damage was significantly decreased in group 3 compared with group 2. CONCLUSIONS: Urtica dioica has a protective effect on the liver in hepatic ischemia-reperfusion-injured rats.

Effect of Urtica dioica L extract on quantitative morphometric alterations of liver parenchymal cells in STZ diabetic rats / Efecto del extracto de Urtica dioica sobre alteraciones morfométricas cuantitativas de las células del parénquima hepático en ratas STZ diabéticas

Diabetes is associated with several structural and functional liver abnormalities that affect glycogen and lipid metabolism. In this study, an attempt was made to evaluate the effects of hydroalcoholic extract of Urtica dioica leaves on Quantitative morphometric changes in parenchymal cells of the livers in STZ diabetic rats. Thirty male Wistar rats were allocated in 3 groups: normal, diabetic and treatment. Hyperglycemia was induced by 80 mg/kg Streptozotocin intraperitoneally. One week after the injection of STZ, the third group received the hydroalcoholic extract of Urtica dioica at 100 mg/kg/day over four weeks. After five weeks, the animals were sacrificed and whole livers were removed. Liver specimens were used for quantitative morphometric analyze after hematoxylin and eosin staining. All data are shown as means plus standard errors of means and were analyzed using One-Way ANOVA test at P<0.05.The mean area of hepatocytes, nuclei and nucleolus had a decrease in periportal zone and an increase in perivenous zone in the diabetic and treatment groups. The increase of hepatocyte area in perivenous zone and reduce of nucleus area in periportal zone was significant in the diabetic group in comparison with control group (P<0.05), but were not significant between treatment and diabetic group. This study showed that administration of 100 mg/kg/day of Urtica dioica leaves extracts after induction of diabetes can cause a little modulating in the main morphometric indices of liver such as area of hepatocytes, nuclei and nucleolus in periportal and perivenous zones.

La diabetes esta asociada con severas anormalidades en la estructura y funcionamiento del hígado que afectan el metabolismo glicogénico y lipídico. En el presente estudio, se evaluó los efectos del extracto hidroalcohólico de Urtica dioica, observando los cambios morfométricos cuantitativos en las células del parénquima hepático de ratas diabéticas STZ. Se utilizaron 30 ratas Wistar, machos, conformando 3 grupos: normal, diabéticas y con tratamiento. Se indujo una hiperglicemia injectando intraperitonealmente con 80 mg/kg de estreptozotocina. Una semana después de la inyección de STZ, el tercer grupo recibió el extracto hidroalcohólico de Urtica dioica en dosis de 100mg/kg/día por 4 semanas. Después de 5 semanas, los animales fueron sacrificados y sus hígados removidos.Las muestras de hígado fueron usadas para análisis morfométrico cuantitativo y posteriormente teñidos con hematoxilina eosina. Los datos son mostrados como promedios con sus respectivas desviaciones Standard y fueron analizados con un test de ANOVA con un p menor a 0,05. El área promedio de los hepatocitos, núcleos y nucléolos tuvieron una disminución en la zona periportal y un incremento en la zona perivenosa en los grupos diabético y con tratamiento. El incremento del área del hepatocito en la zona perivenosa y la reducción del área nuclear en la zona periportal fue significativa en el grupo diabético en comparación con el grupo control (p menor que 0,05), pero no fue significativo entre las ratas tratadas y el grupo diabético. Este estudio mostró que la administración de 100 mg/kg/día de extracto de Urtica dioica después de la inducción de diabetes puede causar una pequeña modulación en los índices morfométricos principales del hígado, tales como: área de los hepatocitos, núcleos y nucléolos en las zonas periportal y perivascular.

Hepatoprotective effects of setarud against carbon tetrachloride-induced liver injury in rats.

To assess the hepatoprotective activity of a new herbal drug "setarud" in experimental liver fibrosis, 48 male Wistar rats were divided into four groups: controls, carbon tetrachloride (CCl4) group, and two treatment groups that received CCl4 and setarud at doses of 0.02 or 0.04 g/Kg/day for 30 days. Body weight gain, biochemical liver tests, bile flow rate and composition, and changes in liver morphology in the four groups were studied. CCl4 administration led to morphological and biochemical evidence of liver injury as compared to untreated controls. Setarud administration led to significant protection against CCl4-induced changes in body weight gain, liver morphology, bile flow and concentration. It was also associated with significantly lower serum liver enzyme levels (p<0.01), higher serum albumin level, and reduced increase in narcotic-induced sleeping time. Thus, setarud showed protective activity against CCl4-induced hepatotoxicity in rats. Further studies of its efficacy in liver disease are warranted.

Protective effect of natural honey, urtica diocia and their mixture against oxidative stress caused by chronic ethanol consumption

Compliance/adherence of diabetic patients towards different therapeutic aspects [other than drugs] is considered one of the most important elements to control diabetes mellitus [DM]. A cross sectional study was conducted on 283 diabetic patients chosen by systematic random sample among those attending Alf-Maskan Health Insurance Outpatients clinics in East Cairo, [from April- May 2007], to assess their compliance behaviors in relation to management of their disease.Showed that most of the diabetics [61.1%] had a poor total compliance rate for the therapeutic tasks of [DM] as a whole, though the larger proportion of the diabetics [44.9%] had a satisfactory overall knowledge about the important items of DM. As regards the individual therapeutic tasks, there were also poor compliance rates concerning diet regimen, regular exercise, cessation of smoking, weight monitoring and care of eye and foot. Good compliance rate was significantly higher among patients who were males, highly educated, those of high socioeconomic level, those who had better knowledge about the disease and those who had suffered from multiple co-morbidities and suffered from DM at least ten years. Recommendations were suggested to improve patient compliance towards management tasks of the disease through health education program because increasing the information of the patients about the disease and its complications through the shared health care team including the patient himself was valuable